In human metastatic breast cancer patients the CSF1-R+ myeloid cells showed CSF1-ETS2 induced higher expression of miR-21 and miR-29a which correlated with higher metastatic tumor burden [128]. The gene discussed is CSF1R; the disease is neoplasm.